lacosamide

FDA Drug Profile — Lacosamide, lacosamide, Vimpat, MOTPOLY XR

lacosamide is listed in the FDA National Drug Code directory with 44 NDC codes, marketed under brand names including Lacosamide, lacosamide, Vimpat. Available dosage forms: injection, tablet, film coated, powder, capsule, extended release, solution.

Drug details

Generic Name
lacosamide
Brand Names
Lacosamide, lacosamide, Vimpat, MOTPOLY XR
Application Number
ANDA216670
Sponsor
Apotex Corp
NDC Codes
44
Dosage Forms
INJECTION, TABLET, FILM COATED, POWDER, CAPSULE, EXTENDED RELEASE, SOLUTION, INJECTION, SOLUTION
Routes
INTRAVENOUS, ORAL
Active Ingredients
LACOSAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Lacosamide oral solution is indicated for: Treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Lacosamide oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide oral solution is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.